Romulus Brazzell
Technik-/Wissenschafts-/F&E-Leiter bei KALA BIO, INC.
Vermögen: 29 151 $ am 30.04.2024
Aktive Positionen von Romulus Brazzell
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
KALA BIO, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2013 | - |
Mimetogen Pharmaceuticals, Inc.
Mimetogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Mimetogen Pharmaceuticals, Inc. develops peptidomimetic small molecule drugs against glaucoma and cancer. Its product mimic the effects of neurotrophin proteins that help to maintain the health and growth of cells and tissues found in the eye. Mimetogen provides tyrosine kinase agonists that prevent neuronal death; small molecule tyrosine kinase receptor agonists, which stimulates mucin secretion from conunctival goblet cells; and small molecule neurotrophin mimetics that rescues retinal pigment epithelial cells from oxidative stress-induced apoptosis. The company was founded by Garth Cumberlidge and H. Uri Saragovi in 2005 and is headquartered in Montreal, Canada. | Direktor/Vorstandsmitglied | 01.01.2024 | - |
Karriereverlauf von Romulus Brazzell
Ehemalige bekannte Positionen von Romulus Brazzell
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Acuity Advisors LLC
Acuity Advisors LLC Investment ManagersFinance Acuity Advisors LLC is a private company that provides brand strategy, digital experience, custom applications, solution management, design, brand identity, user experience, information design, print design, and technology development services. The company is based in Woodstock, GA. The company helps their clients create their digital strategy and turn it into action through digital experience, storytelling, intelligent technology, and results measured down to each user. | Corporate Officer/Principal | 01.01.2014 | 01.07.2018 |
Mimetogen Pharmaceuticals, Inc.
Mimetogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Mimetogen Pharmaceuticals, Inc. develops peptidomimetic small molecule drugs against glaucoma and cancer. Its product mimic the effects of neurotrophin proteins that help to maintain the health and growth of cells and tissues found in the eye. Mimetogen provides tyrosine kinase agonists that prevent neuronal death; small molecule tyrosine kinase receptor agonists, which stimulates mucin secretion from conunctival goblet cells; and small molecule neurotrophin mimetics that rescues retinal pigment epithelial cells from oxidative stress-induced apoptosis. The company was founded by Garth Cumberlidge and H. Uri Saragovi in 2005 and is headquartered in Montreal, Canada. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2012 | 01.12.2015 |
Inspire Pharmaceuticals, Inc.
Inspire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Inspire Pharmaceuticals, Inc. operated as a biopharmaceutical company. It discovered and developed pharmaceutical products to treat diseases that results from deficiencies in the body's natural mechanisms of mucosal hydration. The company was founded by Kendall Harden, Richard C. Boucher, Andre L. Lamotte, H. Jefferson Leighton and Terrance G. McGuire and was headquartered in Whitehouse Station, NJ. | Technik-/Wissenschafts-/F&E-Leiter | 02.07.2010 | 01.01.2011 |
Corporate Officer/Principal | 05.08.2009 | 02.07.2010 | |
Novartis Ophthalmics, Inc.
Novartis Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Ophthalmics, Inc. was a producer of pharmaceuticals, eye care and generic drugs. The company was headquartered in Duluth, GA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2000 | 01.01.2004 |
Ciba Vision Ophthalmics Co. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1996 | 01.01.2000 |
Alcon Laboratories, Inc.
Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1990 | 01.01.1991 |
Ausbildung von Romulus Brazzell
University of Kentucky | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Kanada | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 6 |
Corporate Officer/Principal | 2 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 6 |
Consumer Services | 2 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
KALA BIO, INC. | Health Technology |
Private Unternehmen | 6 |
---|---|
Inspire Pharmaceuticals, Inc.
Inspire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Inspire Pharmaceuticals, Inc. operated as a biopharmaceutical company. It discovered and developed pharmaceutical products to treat diseases that results from deficiencies in the body's natural mechanisms of mucosal hydration. The company was founded by Kendall Harden, Richard C. Boucher, Andre L. Lamotte, H. Jefferson Leighton and Terrance G. McGuire and was headquartered in Whitehouse Station, NJ. | Health Technology |
Novartis Ophthalmics, Inc.
Novartis Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Ophthalmics, Inc. was a producer of pharmaceuticals, eye care and generic drugs. The company was headquartered in Duluth, GA. | Health Technology |
Alcon Laboratories, Inc.
Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Health Technology |
Mimetogen Pharmaceuticals, Inc.
Mimetogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Mimetogen Pharmaceuticals, Inc. develops peptidomimetic small molecule drugs against glaucoma and cancer. Its product mimic the effects of neurotrophin proteins that help to maintain the health and growth of cells and tissues found in the eye. Mimetogen provides tyrosine kinase agonists that prevent neuronal death; small molecule tyrosine kinase receptor agonists, which stimulates mucin secretion from conunctival goblet cells; and small molecule neurotrophin mimetics that rescues retinal pigment epithelial cells from oxidative stress-induced apoptosis. The company was founded by Garth Cumberlidge and H. Uri Saragovi in 2005 and is headquartered in Montreal, Canada. | Health Technology |
Ciba Vision Ophthalmics Co. | |
Acuity Advisors LLC
Acuity Advisors LLC Investment ManagersFinance Acuity Advisors LLC is a private company that provides brand strategy, digital experience, custom applications, solution management, design, brand identity, user experience, information design, print design, and technology development services. The company is based in Woodstock, GA. The company helps their clients create their digital strategy and turn it into action through digital experience, storytelling, intelligent technology, and results measured down to each user. | Finance |
- Börse
- Insiders
- Romulus Brazzell
- Erfahrung